Class information for:
Level 1: PRAME//LEUKEMIA ASSOCIATED ANTIGENS//UNIT 900

Basic class information
ID Publications Average number
of references		 Avg. shr. active
ref. in WoS
16129 604 43.9 91%


Bar chart of Publication_year

Last years might be incomplete

Classes in level above (level 2)


ID, lev.
above		 Publications Label for level above
151 22214 IMMUNOTHERAPY//DENDRITIC CELLS//CANCER IMMUNOLOGY IMMUNOTHERAPY

Terms with highest relevance score


Rank Term Type of term Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class
1 PRAME Author keyword 36 69% 5% 31
2 LEUKEMIA ASSOCIATED ANTIGENS Author keyword 7 53% 2% 10
3 UNIT 900 Address 6 71% 1% 5
4 PREFERENTIALLY EXPRESSED ANTIGEN OF MELANOMA Author keyword 6 100% 1% 4
5 CANC VACCINE TEAM Address 4 75% 0% 3
6 MLAA 34 Author keyword 3 100% 0% 3
7 BONE MARROW TRANSPLANTAT IMMUNOTHER Y Address 2 44% 1% 4
8 ANTILEUKEMIC EFFECTS Author keyword 2 67% 0% 2
9 DENDRITIC LIKE CELL Author keyword 2 67% 0% 2
10 TRANSPLANTAT IMMUNOL SECT Address 2 67% 0% 2

Web of Science journal categories

Author Key Words


Rank Web of Science journal category Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class		 LCSH search Wikipedia search
1 PRAME 36 69% 5% 31 Search PRAME Search PRAME
2 LEUKEMIA ASSOCIATED ANTIGENS 7 53% 2% 10 Search LEUKEMIA+ASSOCIATED+ANTIGENS Search LEUKEMIA+ASSOCIATED+ANTIGENS
3 PREFERENTIALLY EXPRESSED ANTIGEN OF MELANOMA 6 100% 1% 4 Search PREFERENTIALLY+EXPRESSED+ANTIGEN+OF+MELANOMA Search PREFERENTIALLY+EXPRESSED+ANTIGEN+OF+MELANOMA
4 MLAA 34 3 100% 0% 3 Search MLAA+34 Search MLAA+34
5 ANTILEUKEMIC EFFECTS 2 67% 0% 2 Search ANTILEUKEMIC+EFFECTS Search ANTILEUKEMIC+EFFECTS
6 DENDRITIC LIKE CELL 2 67% 0% 2 Search DENDRITIC+LIKE+CELL Search DENDRITIC+LIKE+CELL
7 ZRF1 2 67% 0% 2 Search ZRF1 Search ZRF1
8 PR1 2 24% 1% 7 Search PR1 Search PR1
9 LEUKEMIA ASSOCIATED ANTIGEN 2 43% 0% 3 Search LEUKEMIA+ASSOCIATED+ANTIGEN Search LEUKEMIA+ASSOCIATED+ANTIGEN
10 ELUTED PEPTIDES 1 100% 0% 2 Search ELUTED+PEPTIDES Search ELUTED+PEPTIDES

Key Words Plus


Rank Web of Science journal category Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class
1 B3A2 PEPTIDE 33 100% 2% 13
2 JOINING REGION 17 59% 3% 19
3 WT1 PEPTIDE 16 51% 4% 23
4 SERUM FREE GENERATION 12 86% 1% 6
5 MELANOMA PRAME 8 75% 1% 6
6 ANTIGEN PRAME 6 71% 1% 5
7 BLASTS 5 15% 5% 30
8 ACTIVE SPECIFIC IMMUNIZATION 4 67% 1% 4
9 PREFERENTIALLY EXPRESSED ANTIGEN 4 56% 1% 5
10 WT1 PEPTIDE VACCINATION 3 22% 2% 12

Journals

Reviews


Title Publ. year Cit. Active references % act. ref.
to same field
Leukemia-associated antigens and their relevance to the immunotherapy of acute myeloid leukemia 2012 32 104 25%
Dendritic cell vaccination in acute myeloid leukemia 2012 10 64 53%
A causal role for the human tumor antigen preferentially expressed antigen of melanoma in cancer 2006 35 25 56%
Leucine-rich repeat protein PRAME: expression, potential functions and clinical implications for leukaemia 2010 12 63 51%
Clinical trials of dendritic cell-based cancer vaccines in hematologic malignancies 2014 2 78 23%
Immunotherapy of Acute Myeloid Leukemia: Current Approaches 2009 24 121 36%
Immunotherapy prospects for acute myeloid leukaemia 2010 34 97 22%
The role of peptide and DNA vaccines in myeloid leukemia immunotherapy 2013 4 58 31%
Translational mini-review series on vaccines: Peptide vaccines for myeloid leukaemias 2007 21 103 32%
Leukemia-associated antigens as target structures for a specific immunotherapy in chronic myeloid leukemia 2008 12 59 51%

Address terms


Rank Address term Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class
1 UNIT 900 6 71% 0.8% 5
2 CANC VACCINE TEAM 4 75% 0.5% 3
3 BONE MARROW TRANSPLANTAT IMMUNOTHER Y 2 44% 0.7% 4
4 TRANSPLANTAT IMMUNOL SECT 2 67% 0.3% 2
5 SECT TRANSPLANTAT IMMUNOL 2 17% 1.7% 10
6 STEM CELL ALLOTRANSPLANTAT SECT 1 19% 1.0% 6
7 JOHN HUGHES BENNETT 1 16% 1.0% 6
8 ADULT ONCOL PEDIAT ONCOL 1 50% 0.2% 1
9 CANC AMSTERDAM HEMATOL 1 50% 0.2% 1
10 CANC SCI MP824 1 50% 0.2% 1

Related classes at same level (level 1)


Rank Relatedness score Related classes
1 0.0000220608 CXXC5//THEOPHYLLAMINE//BIOCHIP ARRAY
2 0.0000206497 MINOR HISTOCOMPATIBILITY ANTIGENS//MINOR HISTOCOMPATIBILITY ANTIGEN//HA 1
3 0.0000169674 DENDRITIC CELLS//DENDRITIC CELL//TUMOR LYSATE
4 0.0000143886 MHC NONRESTRICTED CYTOTOXICITY//HISTAMINE DIHYDROCHLORIDE//BOWYER ONCOL
5 0.0000118015 WT1//DENYS DRASH SYNDROME//WILMS TUMOR GENE
6 0.0000112048 REDUCED INTENSITY CONDITIONING//DONOR LYMPHOCYTE INFUSION//REDUCED INTENSITY
7 0.0000105290 CANCER TESTIS ANTIGEN//CANCER TESTIS ANTIGENS//NY ESO 1
8 0.0000101754 IDIOTYPE//IDIOTYPE VACCINATION//CELL THER Y AREA
9 0.0000073636 INTERDISCIPLINARY STUDIES SECT//BIOL SCI TUNIS//BLOOD TRANSFUS 1
10 0.0000072157 BELAGENPUMATUCEL L//SRL172//PA MSHA